Stay updated on Nivolumab Combinations in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combinations in Urothelial Cancer Clinical Trial page.

Latest updates to the Nivolumab Combinations in Urothelial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check27 days agoChange DetectedThe page has been updated to include new information about the drug Cisplatin and Carboplatin in relation to Urothelial Cancer, while significant details about the investigational immunotherapy study involving nivolumab and ipilimumab have been removed.SummaryDifference8%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check50 days agoChange DetectedThe web page has been updated to version 2.14.3, replacing the previous version 2.14.2.SummaryDifference0.1%
- Check86 days agoChange DetectedThe web page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check100 days agoChange DetectedThe website has updated to revision v2.14.2, with a notice that some NLM-NCBI services are experiencing heavy traffic, potentially affecting performance and availability.SummaryDifference1%
Stay in the know with updates to Nivolumab Combinations in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in Urothelial Cancer Clinical Trial page.